Equatorial Guinea vs Senegal: Previously treated cases tested for RR-/MDR-TB
Equatorial Guinea
88.0%
in 2024
Senegal
87.0%
in 2024
Equatorial Guinea rank
90th
Senegal rank
92nd
Previously treated cases tested for RR-/MDR-TB over time
- Equatorial Guinea
- Senegal
How they compare
Equatorial Guinea currently reports 88.0% against 87.0% in Senegal, a difference of 1.0%.
The two have swapped places 3 times across 13 shared years of data; in 2008 it was Senegal ahead.
Equatorial Guinea ranks 90th and Senegal ranks 92nd of 180 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 2.7% | 2.7% | Senegal |
| 2010s | 45.9% | 79.5% | 33.6% | Senegal |
| 2020s | 60.6% | 88.6% | 28.0% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Equatorial Guinea or Senegal?
- Equatorial Guinea, at 88.0% against 87.0% in Senegal as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Equatorial Guinea and Senegal?
- 1.0%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Senegal?
- 13 years are reported by both, from 2008 to 2024.
- How do Equatorial Guinea and Senegal rank globally for previously treated cases tested for rr-/mdr-tb?
- Equatorial Guinea ranks 90th and Senegal ranks 92nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.